Asembia Announces the ASPN Digital Retail Network™ with Advanced Technology for Enhanced Prescription Access

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

A Specialty-lite Strategy for Primary Care Therapies Now Integrates Real-Time Prescription Visibility, Proprietary BV Solutions, and DoorDash® Delivery.

FLORHAM PARK, N.J., April 16, 2025 /PRNewswire/ — Asembia proudly announces its ASPN Digital Retail Network™, the industry’s most extensive pharmacy network encompassing retail, digital, payor-owned, chain, and independent pharmacies. This cutting-edge platform enhances ASPN’s end-to-end digital prescription process by integrating real-time prescription visibility, proprietary benefit verification (BV) solutions for both pharmacy and medical coverage, and partnerships with leading national pharmacies.

The ASPN Digital Retail Network™ has electronically integrated with thousands of retail pharmacies to simplify the prescription transfer process, optimizing patient support services and accelerating speed to therapy. ASPN’s proprietary BV solution solves for pharmacy benefit complexities, ensuring seamless medication access while reducing barriers to treatment.

To further enhance patient convenience, ASPN has integrated DoorDash® prescription delivery, enabling patients to receive medications quickly and reliably from their preferred pharmacy. With expanded capabilities, the network helps reduce prescription abandonment and substitution, improve copay utilization, and offer patients the flexibility of local pharmacy pick-up or at-home delivery.

Beyond prescription fulfillment, Asembia’s complementary service offerings—including GPO, digital hub, data insights, and distribution—deliver integrated solutions for pharmaceutical clients, improving patient access and overall therapy experience.

“By combining proprietary technology with an expansive and diverse pharmacy network, we are transforming how patients access specialty-lite and primary care therapies,” said Asembia Co-Founder and CEO Lawrence Irene. “With real-time prescription visibility, BV Solutions, and services like DoorDash® delivery, we ensure patients receive uninterrupted treatment while providing pharmaceutical partners with a seamless, data-driven experience.”

Asembia will showcase the ASPN Digital Retail Network™ at its annual Specialty Pharmacy Summit in Las Vegas, April 27 – May 1, 2025. Now in its 21st year, the event remains the largest U.S. healthcare conference for specialty pharmacy, bringing together more than 8,500 industry leaders from pharma/biotech, health systems, retail pharmacies, payers, and technology innovators.

For more information about the ASPN Digital Retail Network™ use the following link: https://qrcodes.pro/idw6D2

Media Contact: 
Bill Fitzgerald
VP Marketing 
Asembia 
P: 973.564.8004 
E: bill.fitzgerald@asembia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/asembia-announces-the-aspn-digital-retail-network-with-advanced-technology-for-enhanced-prescription-access-302430392.html

SOURCE Asembia

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

13 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

13 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

13 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

13 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

13 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

13 hours ago